• Sanofi teams up with MSD to test new oncology treatment pharmatimes
    October 30, 2020
    Sanofi has entered an agreement with MSD – known as Merck & Co in the US – to collaborate on a phase II trial evaluating its investigational candidate THOR-707 alongside MSD’s immunotherapy Keytruda.
  • Sanofi agrees to pay $2.5bn for biotech firm Synthorx pharmaceutical-technology
    December 10, 2019
    French pharmaceutical company Sanofi has agreed to acquire all outstanding shares of biotechnology firm Synthorx for a total consideration of $2.5bn, or $68 per share in cash.
PharmaSources Customer Service